Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthias Roesslein is active.

Publication


Featured researches published by Matthias Roesslein.


Nanomedicine: Nanotechnology, Biology and Medicine | 2011

Nanomaterial cell interactions: are current in vitro tests reliable?

Cordula Hirsch; Matthias Roesslein; Harald F. Krug; Peter Wick

New properties of engineered nanomaterials raise great expectations for industrial, scientific as well as medical applications. At the same time concerns among consumers regarding the safety aspects of this new technology emerge. Furthermore, among the multitude of published studies, a considerable number do not reveal reliable data. Thus, standardized, validated, reliable, robust, reproducible and intelligent testing strategies are urgently needed that address nanomaterial toxicity. This article discusses the reliability of currently used in vitro toxicity assays. It covers major problems, pitfalls and challenges of assay performance and validation. We recommend a series of different controls to improve the experimental quality and, thus, also the reliability and reproducibility of current in vitro systems. These recommendations consequently applied in the future will increase the safe and sustainable use of nanotechnology.


International Journal of Molecular Sciences | 2013

Comparability of in Vitro Tests for Bioactive Nanoparticles: A Common Assay to Detect Reactive Oxygen Species as an Example

Matthias Roesslein; Cordula Hirsch; Jean-Pierre Kaiser; Harald F. Krug; Peter Wick

The release of reactive oxygen species (ROS) during the electron transport of mitochondrial aerobic respiration is the major source of ROS. However, contact between cells and nanoparticles (NPs) can also induce release of ROS, leading to an imbalance towards the pro-oxidative state. At low levels of ROS production, cells initiate a protective response to guarantee their survival, but an excess of ROS can damage cellular compounds such as membranes and various organelles, or directly cause genotoxicity. Thus an elevated level of ROS is an important indicator of cellular stress and an accurate recording of this parameter would be very informative. ROS can be measured by various assays, but all known assays measuring and quantifying ROS possess certain weaknesses. The problems and challenges of quantitatively detecting ROS in vitro using the 2′,7′-dichlorodihydrofluorescein (DCF) assay is discussed as an example. In addition, we debate the difficulties in finding a suitable and stable chemical reaction control for the DCF assay (or other ROS-detecting assays). As a conclusion, we believe that using 3-morpholinosydnonimine hydrochloride (Sin-1) as a ROS inducer in the DCF assay is feasible only qualitatively. However, a quantitative measurement of the absolute amount of ROS produced and a quantitative comparison between experiments is (at the moment) impossible.


PLOS ONE | 2013

Human Health Risk of Ingested Nanoparticles That Are Added as Multifunctional Agents to Paints: an In Vitro Study

Jean-Pierre Kaiser; Matthias Roesslein; Liliane Diener; Peter Wick

Microorganisms growing on painted surfaces are not only an aesthetic problem, but also actively contribute to the weathering and deterioration of materials. A widely used strategy to combat microbial colonization is the addition of biocides to the paint. However, ecotoxic, non-degradable biocides with a broad protection range are now prohibited in Europe, so the paint industry is considering engineered nanoparticles (ENPs) as an alternative biocide. There is concern that ENPs in paint might be released in run-off water and subsequently consumed by animals and/or humans, potentially coming into contact with cells of the gastrointestinal tract and affecting the immune system. Therefore, in the present study we evaluated the cytotoxic effects of three ENPs (nanosilver, nanotitanium dioxide and nanosilicon dioxide) that have a realistic potential for use in paints in the near future. When exposed to nanotitanium dioxide and nanosilicon dioxide in concentrations up to 243 µg/mL for 48 h, neither the gastrointestinal cells (CaCo-2) nor immune system cells (Jurkat) were significantly affected. However, when exposed to nanosilver, several cell parameters were affected, but far less than by silver ions used as a control. No differences in cytotoxicity were observed when cells were exposed to ENP-containing paint particles, compared with the same paint particles without ENPs. Paint particles containing ENPs did not affect cell morphology, the release of reactive oxygen species or cytokines, cell activity or cell death in a different manner to the same paint particles without ENPs. The results suggest that paints doped with ENPs do not pose an additional acute health hazard for humans.


Journal of Nanobiotechnology | 2017

Cytotoxic effects of nanosilver are highly dependent on the chloride concentration and the presence of organic compounds in the cell culture media

Jean-Pierre Kaiser; Matthias Roesslein; Liliane Diener; Adrian Wichser; Bernd Nowack; Peter Wick

BackgroundNanosilver shows great promise for use in industrial, consumer or medical products because of its antimicrobial properties. However, the underlying mechanisms of the effects of silver nanoparticles on human cells are still controversial. Therefore, in the present study the influence of the chloride concentration and different serum content of culture media on the cytotoxic effects of nanosilver was systematically evaluated.ResultsOur results show that nanosilver toxicity was strongly affected by the composition of the culture media. The chloride concentration, as well as the carbon content affected the silver agglomeration and the complex formation. But also the dissolution of nanosilver and the availability of free silver ions (Ag+) were severely affected by the compositions of the culture media. Cells, only exposed to silver particles in suspension and dissolved silver complexes, did not show any effects under all conditions. Nanosilver agglomerates and silver complexes were not very soluble. Thus, cells growing on the bottom of the culture dishes were exposed to sedimented nanosilver agglomerates and precipitated silver complexes. Locally, the concentration of silver on the cell surface was very high, much higher compared the silver concentration in the bulk solution. The cytotoxic effects of nanosilver are therefore a combination of precipitated silver complexes and organic silver compounds rather than free silver ions.ConclusionsSilver coatings are used in health care products due to their bacteriostatic or antibacterial properties. The assessment of the toxicity of a certain compound is mostly done using in vitro assays. Therefore, cytotoxicity studies of nanosilver using human cell cultures have to be undertaken under well controlled and understood cultivations conditions in order to improve the compatibility of different studies. Especially when eukaryotic versus prokaryotic systems are compared for the evaluation of the use of nanosilver as antibacterial coatings for implants in order to prevent bacterial colonization.


European Journal of Nanomedicine | 2015

In vitro-ex vivo model systems for nanosafety assessment

Peter Wick; Savvina Chortarea; O. Guenat; Matthias Roesslein; Janick Stucki; Stephanie Hirn; Alke Petri-Fink; Barbara Rothen-Rutishauser

Abstract Engineered nanomaterials have unique and novel properties enabling wide-ranging new applications in nearly all fields of research. As these new properties have raised concerns about potential adverse effects for the environment and human health, extensive efforts are underway to define reliable, cost- and time-effective, as well as mechanistic-based testing strategies to replace the current method of animal testing, which is still the most prevalent model used for the risk assessment of chemicals. Current approaches for nanomaterials follow this line. The aim of this review is to explore and qualify the relevance of new in vitro and ex vivo models in (nano)material safety assessment, a crucial prerequisite for translation into applications.


Journal of Physics: Conference Series | 2011

A novel comprehensive evaluation platform to assess nanoparticle toxicity in vitro

C Hirsch; Jean-Pierre Kaiser; F Wessling; Kathrin Fischer; Matthias Roesslein; Peter Wick; Harald F. Krug

The amount of engineered nanomaterials (ENM) is constantly increasing. Their unique properties, compared to their bulk counterparts, render them suitable for various applications in many areas of life. Hence, nanomaterials appear in a variety of different consumer products leading to the exposure of human beings and the environment during their lifecycle. Even though results on biological effects of ENM are available, harmonized and validated test systems are still missing. One major problem concerning the reliable and robust toxicity testing arises from interactions of ENM with different assay systems. Modifications or damage to DNA can have fatal consequences, such as the formation of tumor cells and hence carcinogenesis. Therefore we focused on the re-evaluation of two genotoxicity assays concerning their nanomaterial compatibility; namely the cytokinesis-block micronucleus cytome assay (MN-assay) and the alkaline single cell gel electorphoresis assay (comet assay). We demonstrate the interference of ENM agglomerates with the read-out of both assays and discuss possibilities how to acquire relevant genotoxicity data.


Journal of Micro and Nano-Manufacturing | 2017

Benchmark of Nanoparticle Tracking Analysis on Measuring Nanoparticle Sizing and Concentration

Ciaran Manus Maguire; Katherine Sillence; Matthias Roesslein; Claire Hannell; Guillaume Suarez; Jean-Jacques Sauvain; Sonja Capracotta; Servane Contal; Sébastien Cambier; Naouale El Yamani; Maria Dusinska; Agnieszka Dybowska; Antje Vennemann; Laura Cooke; Andrea Haase; Andreas Luch; Martin Wiemann; Arno C. Gutleb; Rafi Korenstein; Michael Riediker; Peter Wick; Patrick Hole; Adriele Prina-Mello

One of the greatest challenges in the manufacturing and development of nanotechnologies is the requirement for robust, reliable, and accurate characterization data. Presented here are the results of an interlaboratory comparison (ILC) brought about through multiple rounds of engagement with NanoSight Malvern and ten pan-European research facilities. Following refinement of the nanoparticle tracking analysis (NTA) technique, the size and concentration characterization of nanoparticles in liquid suspension was proven to be robust and reproducible for multiple sample types in monomodal, binary, or multimodal mixtures. The limits of measurement were shown to exceed the 30–600 nm range (with all system models), with percentage coefficients of variation (% CV) being calculated as sub 5% for monodisperse samples. Particle size distributions were also improved through the incorporation of the finite track length adjustment (FTLA) algorithm, which most noticeably acts to improve the resolution of multimodal sample mixtures. The addition of a software correction to account for variations between instruments also dramatically increased the accuracy and reproducibility of concentration measurements. When combined, the advances brought about during the interlaboratory comparisons allow for the simultaneous determination of accurate and precise nanoparticle sizing and concentration data in one measurement.


Colloids and Surfaces B: Biointerfaces | 2018

Interference of engineered nanomaterials in flow cytometry: A case study

Nils Bohmer; Alexandra Rippl; Sarah May; Aurélie Walter; Min Beom Heo; Minjeong Kwak; Matthias Roesslein; Nam Woong Song; Peter Wick; Cordula Hirsch

Nanotechnology is regarded as the enabling technology of the 21st century. However, only a relatively small number of nano-enabled medical and healthcare products finally made their way to the market. There are several reasons why such innovative approaches fail in translation, with one key factor being the uncertainty surrounding their safety assessment. Although well described, interference reactions of engineered nanomaterials (ENM) with classical cytotoxicity assays remain a major source of uncertainty. Flow cytometry is a powerful, widely used, in vitro technique. Its readout is based on the detection of refracted laser light and fluorescence signals. It is therefore susceptible to ENM interference. Here we investigated possible interferences of ENM in the Annexin V/propidium iodide (PI) assay, which quantifies apoptotic and necrotic cell populations by flow cytometry. Two case studies were conducted using either silica or gold nanoparticles differing in size, specific surface area and surface chemistry. Both ENM types were found to cause distinct interference reactions at realistic concentrations. Silica particles induced false-positive signals; however only in the absence of a protein corona and in conjunction with a particular fluorophore combination (FITC/PI). In contrast, gold particles led to complex quenching effects which were only marginally influenced by the presence of proteins and occurred for both fluorophore combinations analyzed. We present a versatile spike-in approach which is applicable to all ENM and cell types. It further allows for the identification of a broad range of different interference phenomena, thereby increasing the reliability and quality of flow cytometry and ENM hazard assessment.


Journal of Nanoparticle Research | 2013

Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA)

Patrick Hole; Katherine Sillence; Claire Hannell; Ciaran Manus Maguire; Matthias Roesslein; Guillaume Suarez; Sonja Capracotta; Zuzana Magdolenova; Limor Horev-Azaria; Agnieszka Dybowska; Laura Cooke; Andrea Haase; Servane Contal; Stein Manø; Antje Vennemann; Jeans-Jacques Sauvain; Kieran Crosbie Staunton; Sergio Anguissola; Andreas Luch; Maria Dusinska; Rafi Korenstein; Arno C. Gutleb; Martin Wiemann; Adriele Prina-Mello; Michael Riediker; Peter Wick


Journal of Nanoparticle Research | 2011

Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment

Gert Roebben; Sonia Ramirez-Garcia; Vincent A. Hackley; Matthias Roesslein; Frederick Klaessig; Vikram Kestens; Iseult Lynch; C. M. Garner; A. Rawle; Alison Elder; Vicki L. Colvin; Wolfgang G. Kreyling; Harald F. Krug; Zuzanna A. Lewicka; Scott E. McNeil; Andre E. Nel; Anil K. Patri; Peter Wick; Mark R. Wiesner; Tian Xia; Günter Oberdörster; Kenneth A. Dawson

Collaboration


Dive into the Matthias Roesslein's collaboration.

Top Co-Authors

Avatar

Peter Wick

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Harald F. Krug

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Cordula Hirsch

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Jean-Pierre Kaiser

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Bruno Wampfler

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Guillaume Suarez

École Polytechnique Fédérale de Lausanne

View shared research outputs
Top Co-Authors

Avatar

Liliane Diener

Swiss Federal Laboratories for Materials Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Andrea Haase

Federal Institute for Risk Assessment

View shared research outputs
Top Co-Authors

Avatar

Andreas Luch

Federal Institute for Risk Assessment

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge